Additional licensing partnerships for CBS9106 in Japan, China, Taiwan, South Korea and other territories

An initiative to secure partnership partners in excluded territories, including Japan, China, Taiwan and South Korea, for CBS9106 and expand the worldwide rights-granting, development and commercialization framework. It covers regional licensing partnerships for a specific drug candidate.